Analyst Ratings for Gossamer Bio Inc. (GOSs)
GOSs Rating Summary
GOSs Price Target Summary
- Highest: $90.00 (H.C. Wainwright)
- Lowest: $0.28 (Barclays)
- Average: $14.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$14.25 (+21.9%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
Avg. $ Target:
$14.25 (+21.9%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | Leerink | Joseph Schwartz | Upgrade | Outperform (Market Perform) |
1.00 (N/A) |
0.14 (11.69) |
8250% | Details |
| 3/23/2026 | Cantor Fitzgerald | Olivia Brayer | Downgrade | Neutral (Overweight) |
N/A (N/A) |
0.45 (11.69) |
2497.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
